Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Argus Health
US Department of Justice
Colorcon
McKinsey
UBS
Mallinckrodt
Medtronic

Generated: June 24, 2018

DrugPatentWatch Database Preview

HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Hydralazine, Hydrochlorothiazide W/ Reserpine, and what generic alternatives are available?

Hydralazine, Hydrochlorothiazide W/ Reserpine is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE is hydralazine hydrochloride; hydrochlorothiazide; reserpine. There are twenty drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide; reserpine profile page.
Summary for HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
Drug patent expirations by year for HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE

US Patents and Regulatory Information for HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085771-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
Cantor Fitzgerald
Mallinckrodt
Deloitte
Express Scripts
Chubb
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.